IDEA-FAST Webinar: New ways of measuring fatigue and sleep disturbances in chronic diseases
We are excited to announce the upcoming webinar by IDEA-FAST, which will be held on 7 June 2023 from 2:00 to 4:00 PM CET. This informative session will explore the latest advancements in research, and how digital assessment can enhance current research and treatment opportunities. Our distinguished panel of speakers will share their expertise on […]
Early Career Researcher Spotlight – Jennifer Kudelka
In the second spotlight we talk to Dr. Jennifer Kudelka. She is a medical doctor at the Department of Neurology of the University Hospital in Kiel. After finishing her medical studies in 2021 and completing her doctoral thesis in neurogeriatrics, she started a position as a clinician scientist, which allows her to combine clinical and […]
Interview with New Associate PI of Newcastle
Dr. Jan Dixon, physician and researcher at the Royal Victoria Infirmary, Newcastle, is the new Associate Principal Investigator of UNEW in the IDEA-FAST project. 1. You’re the new associate principal investigator of the NEWCASTLE. What does this entail? Can you walk us through your new role and associated responsibilities? This role offers an opportunity to […]
Early Career Researcher Spotlight – Chloe Hinchliffe
We are launching a new segment to present the work of Early Career Researchers in IDEA-FAST. In this first instalment, we talk to Chloe Hinchliffe, a postdoctoral researcher in the Brain and Movement (BAM) Research Group at the Translational and Clinical Research Institute of Newcastle University. Chloe received her integrated master’s degree in Medical Engineering (MEng) at the […]
New Paper Published on Fatigue and Sleep Assessment through Digital Wearables
Our newly published research presents results on using wearable sensing technology to assess fatigue and sleep in patients with chronic diseases. The article provides clinicians with insights on monitoring patients in the natural everyday settings of a patient’s daily life. In the future, wearable sensors could capture the effect the disease has on the patient’s […]
Data Standards in IDEA-FAST
One of the main goals of the IDEA-FAST project is to identify novel digital measures for fatigue and sleep disturbances. To achieve this goal, a large amount of data, including clinical data (e.g., demographic data of the recruited patients) and device data (e.g., data collected by sensors and wearable devices for monitoring fatigue, sleep and […]
Sleepless society – The socioeconomic burden of sleep disturbances
“Being up with the lark”, “the early bird catches the worm”, or “being a night owl” – these phrases are all familiar. A work-focused and digitally connected culture produces the notion of constant availability and the pressure of maximizing time, even if this comes at the expense of our sleep. Looking at sleep patterns, there is a trend towards shorter […]
Benefits of IDEA-FAST outcomes for those affected by fatigue und sleep disorders
My family and I moved from southern Germany to northern Germany four years ago. It is beautiful here. However, there is something that I perceive as incriminating: In winter, there is about one hour less daylight than in the south of Germany. I have the feeling that the lack of this time of daylight makes […]
Health and remote monitoring
There is no doubt that the global pandemic caused by COVID-19 has impacted all sectors of society and the whole population, especially citizens affected by chronic diseases. In this article we would like emphasise the impact that the pandemic had (and continues to have) on people affected by Parkinson’s, as well as on the opportunities […]
The IDEA-FAST feasibility study – Finding the most promising digital measures for sleep disturbances and fatigue
The aim of the feasibility study, which started in July this year, is to gather information on a variety of potential digital measures captured with different devices and their ability of reflecting sleep disturbances or fatigue. Apart from comparing data between different measures from patients with neurodegenerative disorders or immune-mediated inflammatory diseases as well as […]
